Managing Pain in Patients With MTP Arthritis
Hallux Rigidus
About this trial
This is an interventional treatment trial for Hallux Rigidus focused on measuring 1st metatarsophalangeal joint arthritis, 1st MTP arthritis, Hallux Rigidus, foot, Insole, carbon fiber insole, Morton extension insole
Eligibility Criteria
Inclusion Criteria:
- Adult patients (over 18 years old) with MTP joint arthritis
- Adults who were competent and able to consent on their behalf
- Patients who were seen at Massachusetts General Hospital and Newton Wellesley Hospital
Exclusion Criteria:
- Patients who had history of 1st MTP joint injection
- Patients that have already used similar orthotics or had prior surgery to the foot
- Patients who will be treated surgically
Sites / Locations
- Massachusetts General Hospital
- Newton Wellesley Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Vktory Carbon fiber insoles
Morton's extension insoles
VKTRY insoles were initially designed to increase ground force leading to a harder push off for faster running or higher jumping. To enable energy return the insole needed to be extremely rigid and therefore consists out of a full length Carbon-Fiber base. Unexpectedly the Carbon fiber base makes this a highly rigid construct which will likely benefit those patients with MTP arthritis as it will take away much movement of the MTP joint, without having an uncomfortable shape, i.e. patients can use this insole in their own shoes, possibly leading to a higher patient compliance and, simultaneously, to better outcome
Based on expert opinions, it seems the Morton extensions may alleviate pain but are also poorly tolerated by patients due to its uncomfortable shape, coincidently leading to a low patient compliance rate.